Compile Data Set for Download or QSAR
maximum 50k data
Found 93 Enz. Inhib. hit(s) with all data for entry = 7099
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174187(US9102637, 222)
Affinity DataIC50:  1.30nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174104(US9102637, 139)
Affinity DataIC50:  1.60nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174202(US9102637, 237)
Affinity DataIC50:  2.30nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174160(US9102637, 195)
Affinity DataIC50:  2.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174186(US9102637, 221)
Affinity DataIC50:  2.60nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174150(US9102637, 185)
Affinity DataIC50:  2.70nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174196(US9102637, 231)
Affinity DataIC50:  2.90nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174185(US9102637, 220)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174215(US9102637, 250)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174173(US9102637, 208)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174203(US9102637, 238)
Affinity DataIC50:  3.10nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174155(US9102637, 190)
Affinity DataIC50:  3.20nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174138(US9102637, 173)
Affinity DataIC50:  3.40nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174211(US9102637, 246)
Affinity DataIC50:  3.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174128(US9102637, 163)
Affinity DataIC50:  3.70nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174190(US9102637, 225)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173989(US9102637, 24)
Affinity DataIC50:  4.10nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174145(US9102637, 180)
Affinity DataIC50:  4.20nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174130(US9102637, 165)
Affinity DataIC50:  4.40nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174183(US9102637, 218)
Affinity DataIC50:  4.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174219(US9102637, 254)
Affinity DataIC50:  4.80nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174168(US9102637, 203)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173982(US9102637, 17)
Affinity DataIC50:  5.10nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174225(US9102637, 260)
Affinity DataIC50:  5.30nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173988(US9102637, 23)
Affinity DataIC50:  5.30nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174167(US9102637, 202)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174035(US9102637, 70)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174224(US9102637, 259)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174166(US9102637, 201)
Affinity DataIC50:  5.60nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174016(US9102637, 51)
Affinity DataIC50:  5.70nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174081(US9102637, 116)
Affinity DataIC50:  5.80nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174103(US9102637, 138)
Affinity DataIC50:  5.80nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174170(US9102637, 205)
Affinity DataIC50:  5.90nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174204(US9102637, 239)
Affinity DataIC50:  5.90nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174169(US9102637, 204)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174213(US9102637, 248)
Affinity DataIC50:  6.10nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174222(US9102637, 257)
Affinity DataIC50:  6.20nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174154(US9102637, 189)
Affinity DataIC50:  6.80nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174209(US9102637, 244)
Affinity DataIC50:  7.10nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174152(US9102637, 187)
Affinity DataIC50:  7.20nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174093(US9102637, 128)
Affinity DataIC50:  7.20nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173998(US9102637, 33)
Affinity DataIC50:  7.5nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174216(US9102637, 251)
Affinity DataIC50:  7.70nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173978(US9102637, 13)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174021(US9102637, 56)
Affinity DataIC50:  8.20nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174227(US9102637, 262)
Affinity DataIC50:  8.40nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174153(US9102637, 188)
Affinity DataIC50:  8.40nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173976(US9102637, 11)
Affinity DataIC50:  8.60nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM173983(US9102637, 18)
Affinity DataIC50:  8.60nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Carna Biosciences

US Patent
LigandPNGBDBM174223(US9102637, 258)
Affinity DataIC50:  8.70nMpH: 7.5 T: 2°CAssay Description:The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 93 total ) | Next | Last >>
Jump to: